Lords criticises slow progress in tackling drug resistant bugsBMJ 2001; 322 doi: https://doi.org/10.1136/bmj.322.7289.754 (Published 31 March 2001) Cite this as: BMJ 2001;322:754
- Lynn Eaton
GPs have made “tangible” progress in reducing the use of antibiotics in the past three years, but there is still a long way to go in tackling drug resistant “superbugs” such as methicillin resistant Staphylococcus aureus (MRSA), said a highly critical report from a House of Lords select committee.
The select committee on science and technology, chaired by Lord Winston, professor of fertility studies at Imperial College School of Medicine …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial